Skip to main content

and
  1. Article

    Open Access

    FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036

    Inhibition of the HER2/ERBB2 receptor is a keystone to treating HER2-positive malignancies, particularly breast cancer, but a significant fraction of HER2-positive (HER2+) breast cancers recur or fail to respo...

    Steven P. Angus, Timothy J. Stuhlmiller, Gaurav Mehta in npj Breast Cancer (2021)

  2. Article

    Open Access

    Rapid spheroid assays in a 3-dimensional cell culture chip

    The spheroid model provides a physiological platform to study cancer cell biology and drug sensitivity. Usage of bovine collagen I for spheroid assays is costly especially when experiments are conducted in 24-...

    Jia Lin Teh, Siti Fairus Abdul Rahman, Gregory Domnic in BMC Research Notes (2021)